Cite
APA Citation
Jone, P., Anderson, M. S., Mulvahill, M. J., Heizer, H., Glodé, M. P., & Dominguez, S. R. (2018). infliximab Plus Intravenous Immunoglobulin (IVIG) Versus IVIG Alone as Initial Therapy in Children With Kawasaki Disease Presenting With Coronary Artery Lesions. Pediatric infectious disease journal, 37(10), . http://access.bl.uk/ark:/81055/vdc_100086403663.0x000036